| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 12/08/2009 | US7629477 mitotic kinesins like KSP inhibitors; for treating cellular proliferative diseases; N-(3-Aminopropyl)-N [(R)-1-3-benzyl-7-chloro-4-oxo-4H-chromen-2-yl)-2-methyl-propyl]-4-methyl-benzamide |
| 12/08/2009 | US7629471 Transcriptional factor, process for producing the same and use thereof |
| 12/08/2009 | US7629468 Neuroprotectants, analgesics or anticonvulsants |
| 12/08/2009 | US7629384 Increasing localized blood flow to tissues; liposomes, collagen emulsions; antiulcer agents; promoting hair growth; treating erectile dysfunction |
| 12/08/2009 | US7629381 Such as picropodophyllin, for the inhibition of the insulin-like growth factor-1 receptor; cancer, psoriasis, artherosclerosis and acromegaly |
| 12/08/2009 | US7629377 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 12/08/2009 | US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 12/08/2009 | US7629363 Diaryl substituted pyridinones |
| 12/08/2009 | US7629362 2-pyridine carboxamide derivatives |
| 12/08/2009 | US7629350 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one |
| 12/08/2009 | US7629341 Human ADAM-10 inhibitors |
| 12/08/2009 | US7629308 Methods relating to muscle selective calcineurin interacting protein (MCIP) |
| 12/08/2009 | US7629146 A nucleic acid molecule that encodes at least one polypeptide useful as antiangiogenic, tumor suppressive and antimigratory agent; inhibits the migration of cultured cells as well as inhibiting angiogenesis, tumor growth, or any other processes that involve the migration of cells in vivo |
| 12/08/2009 | US7629145 Expression vector comprising nucleotide sequences coding endothelial growth factor protein for use in prevention and treatment of cell proliferative and eye disorders |
| 12/08/2009 | US7629005 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating |
| 12/08/2009 | US7628988 Induce cell differentiation; process control |
| 12/08/2009 | US7628984 Micronutrient formulations for pulmonary and heart health |
| 12/08/2009 | US7628983 treating edema with Kallikrein inhibitor; bovine pancreatic trypsin inhibitor mutants; possibly ecallantide |
| 12/08/2009 | CA2434829C New benzoylguanidine salt |
| 12/08/2009 | CA2422807C N-substituted benzothiophenesulfonamide derivatives |
| 12/08/2009 | CA2422354C Pyrazole compounds useful as protein kinase inhibitors |
| 12/08/2009 | CA2422342C Novel amide derivatives and medicinal use thereof |
| 12/08/2009 | CA2419301C Quinazoline derivatives |
| 12/08/2009 | CA2415486C Pyramidine derivatives |
| 12/08/2009 | CA2404725C Extrusion die |
| 12/08/2009 | CA2401996C Bulbous valve and stent for treating vascular reflux |
| 12/08/2009 | CA2389025C Hormonal composition based on a progesterone and an oestrogen and use thereof |
| 12/08/2009 | CA2369979C 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors |
| 12/08/2009 | CA2361525C Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
| 12/08/2009 | CA2355075C Heteroaryl-cyclic acetals |
| 12/08/2009 | CA2314613C Azolo triazines and pyrimidines |
| 12/03/2009 | WO2009146218A2 Compounds including an anti-inflammatory pharmacore and methods of use |
| 12/03/2009 | WO2009146112A1 Compositions and methods for inhibiting sphingosine kinase |
| 12/03/2009 | WO2009145856A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors |
| 12/03/2009 | WO2009145358A2 Medicament for the prophylaxis or treatment of hypertension |
| 12/03/2009 | WO2009144961A1 Substituted carbinol compound having cyclic linker |
| 12/03/2009 | WO2009144933A1 Apoptosis inducer |
| 12/03/2009 | WO2009144551A2 Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potassium level in the blood |
| 12/03/2009 | WO2009144550A2 Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality |
| 12/03/2009 | WO2009144494A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states |
| 12/03/2009 | WO2009144093A1 Hydroxytyrosol benefits mitochondria |
| 12/03/2009 | WO2009144037A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
| 12/03/2009 | WO2009143992A1 2-alkoxy-substituted dicyanopyridines and use thereof |
| 12/03/2009 | WO2009143865A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
| 12/03/2009 | WO2009125987A3 Pharmaceutical formulation |
| 12/03/2009 | WO2009124553A3 Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia |
| 12/03/2009 | WO2009124551A3 Use of vanilloid receptor agonists as hypothermia inducing drugs for the treatment of ischemia |
| 12/03/2009 | WO2009105265A3 Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle |
| 12/03/2009 | WO2009086426A3 Soluble epoxide hydrolase inhibitors for the treatment of endothelial dysfunction |
| 12/03/2009 | WO2009078978A3 Compositions containing polyglycidol-based polymers and uses thereof |
| 12/03/2009 | WO2009043479A3 Use of eaa-mart1 (26-35) for the treatment of human cytomegalovirus infections |
| 12/03/2009 | WO2009043478A3 Use of bubuc and optionally eaa-mart1 (26-35) as a therapeutic agent for the treatment of hcmv infections |
| 12/03/2009 | WO2008115469A3 Role of hedgehog signaling in atherosclerosis and cardiovascular disease |
| 12/03/2009 | US20090298945 Aqueous Extracts from Monocotyledon Plants and Their Use in Cardioprotection |
| 12/03/2009 | US20090298923 Salicylate Conjugates Useful for Treating Metabolic Disorders |
| 12/03/2009 | US20090298918 Alternative Splicing Isoform of Lox-I Protein Encoding Gene, and Uses Thereof |
| 12/03/2009 | US20090298912 Arginase II: A Target treatment of aging heart and heart failure |
| 12/03/2009 | US20090298896 Activating agent for peroxisome proliferator activated receptor delta |
| 12/03/2009 | US20090298886 2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors |
| 12/03/2009 | US20090298883 N-piperidinyl acetamide derivatives as calcium channel blockers |
| 12/03/2009 | US20090298849 Materials and Methods Relating to the Induction of Apoptosis in Target Cells |
| 12/03/2009 | US20090298845 Piperazinyl derivatives as modulators of chemokine receptor activity |
| 12/03/2009 | US20090298837 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-[(Hydrozinooxy)carbonyl]-2,7-dihydro-6-methoxy 3H-pyrido-[4,3,2-de]phthalazin-3-one, used for treating neuron tissue damage resulting from ischemia and reperfusion injury, depression, inflammatory bowel disorders, arthritis, gout, pain and sepsis |
| 12/03/2009 | US20090298833 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 12/03/2009 | US20090298832 Trisubstituted thiazole compounds, preparations methods, pharmaceutical compositions and medicals uses thereof |
| 12/03/2009 | US20090298806 Factor xa inhibitors |
| 12/03/2009 | US20090298789 arresting heart of subject in need of heart surgery by exposing heart to effective amounts of a compound chosen from a potassium channel opener, a potassium channel agonist, an adenosine receptor agonist, and a local anaesthetic under conditions sufficient for heart to be arrested |
| 12/03/2009 | US20090298769 Compounds and methods of modulating angiogenesis |
| 12/03/2009 | US20090298747 Methods and Compositions For Treatment of Nitric Oxide-Induced Clinical Conditions |
| 12/03/2009 | US20090298744 Heterocyclic compounds as adenosine receptor antagonist |
| 12/03/2009 | US20090297634 Compositions for sustrained release of nitric oxide, methods of preparing same and uses thereof |
| 12/03/2009 | US20090297598 Therapeutic combination |
| 12/03/2009 | US20090297583 for controlled release of bioactive agents such as drugs or biodrugs from e.g. a stent; polymeric matrix comprises an agent and a polyamideester having a design that was preselected to provide a predetermined release rate of the combination of agents from the medical article |
| 12/03/2009 | US20090297582 Vascular occlusion devices and methods |
| 12/03/2009 | US20090297576 Local Delivery of PAR-1 Antagonists to Treat Vascular Complications |
| 12/03/2009 | US20090297567 Method For Ultrasound Triggered Drug Delivery Using Hollow Microbubbles With Controlled Fragility |
| 12/03/2009 | US20090297470 Combination of granulocyte-colony stimulating factor (G-CSF) and DPP-IV inhibitors like Vildagliptin or Sitagliptin |
| 12/03/2009 | CA2725545A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
| 12/03/2009 | CA2725111A1 Substituted carbinol compound having a cyclic linker |
| 12/03/2009 | CA2723205A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors |
| 12/03/2009 | CA2721665A1 Compounds including an anti-inflammatory pharmacore and methods of use |
| 12/03/2009 | CA2721491A1 Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potassium level in the blood |
| 12/03/2009 | CA2721489A1 Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality |
| 12/03/2009 | CA2721065A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states |
| 12/03/2009 | CA2721061A1 Treatment of thromboangiitis obliterans by removal of autoantibodies |
| 12/02/2009 | EP2128265A1 Method for glycosylation of flavonoid |
| 12/02/2009 | EP2128248A1 Oligonucleotide compositions with enhanced efficiency |
| 12/02/2009 | EP2128163A1 Spiro-ring compound |
| 12/02/2009 | EP2128158A1 Heterocyclic cyclopropyl-substituted FXR binding compounds |
| 12/02/2009 | EP2128156A1 Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibiting activity |
| 12/02/2009 | EP2128148A1 Compound, alpha 1 adrenaline receptor antagonist, and composition |
| 12/02/2009 | EP2127663A1 Adiponectin production enhancer |
| 12/02/2009 | EP2127654A1 Benzothiazepine derivatives as ryanodine receptor (RYR2) inhibitors and their use in the treatment of cardiac diseases |
| 12/02/2009 | EP2127639A1 Corticosteroid containing liposomes for treatment of cardiovascular diseases |
| 12/02/2009 | EP2126092A2 Fusion proteins binding to growth factors |
| 12/02/2009 | EP2125831A1 Oxazinyl isoflavonoid compounds, medicaments and use |
| 12/02/2009 | EP2125804A1 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazoý4,5-b¨pyridin-2-one derivatives useful as a2b adenosine receptor antagonists |
| 12/02/2009 | EP2125785A1 Indoles |
| 12/02/2009 | EP2125744A1 Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives |
| 12/02/2009 | EP2125695A2 Nitric oxide donor compounds |